Exam 2026-2028 | 250 Practice Questions & ANSWERS |
INSTANT PDF DOWNLOAD
Combined OA & Pre-Assessment Coverage
This practice exam covers pharmacokinetics and pharmacodynamics, ADME, half-life,
loading and maintenance doses, CYP interactions, autonomic pharmacology,
cardiovascular and renal medications, hypertension, heart failure, anticoagulants and
antiplatelets, lipid management, asthma/COPD and allergy medications, endocrine
and diabetes therapies, thyroid and adrenal disorders, psychiatric and neurologic
medications, opioids and reversal agents, antimicrobials, antifungals, antivirals,
antimicrobial stewardship, pregnancy, lactation, geriatrics, pediatrics, adverse drug
reactions, toxicology, drug interactions, patient education, monitoring, and safe
APRN prescribing. This reflects WGU's published description of D116 as an advanced-
practice pharmacology course centered on safe prescribing, monitoring,
pharmacokinetics/pharmacodynamics, pharmacotherapeutic selection, rationale, and
medication outcomes.
Section 1: Pharmacokinetics, Pharmacodynamics & Prescribing Principles
Q1.
Which pharmacokinetic process describes movement of a drug from its site of
administration into systemic circulation?
A. Distribution
B. Metabolism
C. Absorption
D. Excretion
Answer: C
,Rationale: Absorption is the movement of a drug from the administration site into systemic
circulation.
Q2.
Which route provides 100% systemic bioavailability?
A. Oral
B. Sublingual
C. Intramuscular
D. Intravenous
Answer: D
Rationale: IV administration delivers the entire dose directly into systemic circulation.
Q3.
A medication with extensive first-pass hepatic metabolism will generally have:
A. Higher oral bioavailability
B. Lower oral bioavailability
C. Faster renal clearance
D. Greater protein binding
Answer: B
Rationale: First-pass metabolism reduces the amount of an orally administered drug
reaching systemic circulation.
Q4.
Which organ is responsible for most phase I drug metabolism?
,A. Kidney
B. Intestine
C. Liver
D. Lung
Answer: C
Rationale: Hepatic cytochrome P450 enzymes perform many phase I metabolic reactions.
Q5.
Which reaction is characteristic of phase I metabolism?
A. Glucuronidation
B. Sulfation
C. Oxidation
D. Acetylation
Answer: C
Rationale: Phase I reactions include oxidation, reduction, and hydrolysis.
Q6.
Phase II metabolism generally involves:
A. Oxidation only
B. Conjugation
C. Filtration
D. Absorption
Answer: B
Rationale: Phase II reactions attach endogenous molecules to drugs or metabolites to
facilitate elimination.
, Q7.
A medication's half-life is the time required for:
A. Complete elimination
B. Plasma concentration to decrease by 50%
C. Peak concentration to occur
D. Absorption to begin
Answer: B
Rationale: Half-life represents the time needed for the drug concentration to decline by half.
Q8.
A drug has a half-life of 8 hours. Approximately how long would it take to approach steady
state?
A. 8 hours
B. 16 hours
C. 32–40 hours
D. 80 hours
Answer: C
Rationale: Most drugs approach steady state after approximately 4–5 half-lives.
Q9.
A loading dose is used primarily to:
A. Reduce adverse effects
B. Rapidly achieve the target therapeutic concentration
C. Increase drug metabolism
D. Prevent absorption